Define the biology
Choose the cells, material context, spatial relationship and function relevant to the question.
Bioprinting fundamentals
What is 3D bioprinting?
3D bioprinting uses controlled deposition to organise cells, biomaterials and other biological components into experimental structures. The value is not the shape alone. It is the ability to create a model that helps answer a defined biological question.
The basic idea
Place biological materials with purpose.
Cells in the body experience three-dimensional surroundings, neighbouring populations, extracellular matrix and mechanical cues. A bioprinted model can organise selected parts of that environment in a controlled laboratory format.
Select the process
Match deposition and crosslinking to the material, resolution, cell-handling and geometry requirements.
Test the model
Measure print quality, cell response, repeatability and the endpoint needed for scientific interpretation.
A model-development workflow
Printing is one stage, not the whole experiment.
A useful workflow includes cell preparation, material formulation, deposition, crosslinking, culture, quality control and downstream analysis. Plate format, sterility, imaging and sampling can be as important as the print step.
- Biological question and intended endpoint
- Cells, biomaterials and crosslinking route
- Geometry, density and spatial organisation
- Culture, imaging and analytical workflow
- Controls, acceptance criteria and repeatability
When it may add value
Use complexity only when the question needs it.
Potentially useful when
- Cell density is central to the model
- Multiple cell or material regions must be placed
- A defined substrate or plate format is required
- Manual fabrication creates unacceptable variation
- The architecture affects the intended readout
Pause and reassess when
- A simpler 2D or 3D culture answers the question
- The biological endpoint is not yet defined
- Added structure has no clear experimental purpose
- Materials or cells cannot tolerate the process
- No practical measure of model quality exists
JetBio's approach
Modularity follows the application.
JetBio combines ReJI, microvalve and inkjet development capabilities so teams can assess different deposition behaviours around the same biological brief. ReJI was first reported in peer-reviewed work on high-cell-density gels for bone microtissue fabrication.
Read the foundational ReJI publicationReview the published patent record
Frequently asked questions
Start with clear definitions.
What is the difference between 3D printing and 3D bioprinting?
3D printing creates structures from deposited materials. 3D bioprinting applies controlled deposition to biological materials and may include living cells, biomaterials and bioactive components, so cell handling and biological function become part of the process design.
Does a bioprinted model reproduce a whole human organ?
Usually not. Most research models reproduce selected structures, cell interactions or functions needed to study a defined question. Their usefulness depends on the intended context and the evidence supporting that use.
Is every bioink compatible with every printer?
No. Printability depends on material properties, crosslinking, cell requirements, deposition method, geometry and handling conditions. Compatibility should be assessed rather than assumed.
When should a team consider 3D bioprinting?
It is worth considering when manual culture or another fabrication method cannot reliably create the required cell density, spatial pattern, multi-material structure, substrate interface or repeatable format.
Start a useful conversation
Apply the fundamentals to your model.
Share the cells, materials, format and endpoint. JetBio can help assess whether bioprinting is a credible route.